National Cancer Institute; Notice of Closed Meetings, 15362 [2017-06039]
Download as PDF
15362
Federal Register / Vol. 82, No. 58 / Tuesday, March 28, 2017 / Notices
join the online Committee meeting.
There will be no opportunity for oral
public comments during this online
Committee meeting. However, written
comments are welcome throughout the
entire development process of the
national health promotion and disease
prevention objectives for 2030 and may
be emailed to HP2030@hhs.gov.
To join the Committee meeting,
individuals must pre-register at the
Healthy People Web site at https://
www.healthypeople.gov. Participation in
the meeting is limited. Registrations will
be accepted until maximum webinar
capacity is reached and must be
completed by 9:00 a.m. ET on April 26,
2017. A waiting list will be maintained
should registrations exceed capacity,
and those individuals will be contacted
as additional space for the meeting
becomes available. Registration
questions may be directed to: Jim
Nakayama at events@
nakamotogroup.com, or (240) 672–4011.
Date: March 29, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W104, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Eun Ah Cho, Ph.D., Chief,
Special Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W104, Bethesda, MD 20892–9750,
240–276–6342, choe@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Authority: 42 U.S.C. 217a. The Secretary’s
Advisory Committee on National Health
Promotion and Disease Prevention Objectives
for 2030 is governed by provisions of the
Federal Advisory Committee Act (FACA),
Public Law 92–463, as amended (5 U.S.C.,
App.) which sets forth standards for the
formation and use of federal advisory
committees.
Dated: March 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: March 10, 2017.
Don Wright,
Deputy Assistant Secretary for Health
(Disease Prevention and Health Promotion).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–06033 Filed 3–27–17; 8:45 am]
National Library of Medicine; Notice of
Meeting
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Question #10.
VerDate Sep<11>2014
17:14 Mar 27, 2017
Jkt 241001
[FR Doc. 2017–06039 Filed 3–27–17; 8:45 am]
BILLING CODE 4140–01–P
20894, 301–435–5985, dlipman@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS).
Dated: March 22, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–06045 Filed 3–27–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
National Institutes of Health
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of a meeting of the
PubMed Central National Advisory
Committee.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: PubMed Central
National Advisory Committee.
Date: June 21, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: Review and Analysis of Systems.
Place: National Library of Medicine,
Building 38, 2nd Floor, The Lindberg Room,
8600 Rockville Pike, Building 38, Conference
Room B, Bethesda, MD 20892
(Teleconference).
Contact Person: David J. Lipman, MD,
Director, National Center for Biotechnology
Information, National Library of Medicine,
Building 38, Room 8N807, Bethesda, MD
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2); notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for the
treatment of cancer. The outcome of the
evaluation will provide information to
internal NCI committees that will
decide whether NCI should support
requests and make available contract
resources for development of the
potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
E:\FR\FM\28MRN1.SGM
28MRN1
Agencies
[Federal Register Volume 82, Number 58 (Tuesday, March 28, 2017)]
[Notices]
[Page 15362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06039]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Provocative Question #10.
Date: March 29, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W104, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Eun Ah Cho, Ph.D., Chief, Special Review Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W104, Bethesda, MD 20892-9750, 240-
276-6342, choe@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-06039 Filed 3-27-17; 8:45 am]
BILLING CODE 4140-01-P